CANC ETF: Tema Oncology ETF - Price, Holdings & Analysis
Tema Oncology ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About Tema Oncology ETF
What is the current price of CANC?
The latest CANC price is $42.74. The 52-week range is $25.12–$43.29. CANC has returned 69.3% over the past 52 weeks.
What is the expense ratio for CANC?
CANC's annual expense ratio is 0.75%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does CANC pay dividends?
Yes, CANC pays a 0.05% dividend yield. The last ex-dividend date was 2026-12-11. View full dividend history in the Dividends section.
What are the top holdings of CANC?
CANC's largest holdings are Revolution Medicines, Inc. (6.1%), Eli Lilly and Company (5.3%), Cogent Biosciences, Inc. (5.1%) (combined weight: 16.4%). The fund holds 58 total positions. View the complete portfolio breakdown in the Holdings section.
How does CANC compare to similar ETFs?
Compare CANC (0.75% expense ratio, $196M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.